Targeting CHD4 might be highly promising, and the screening of more CHD4 inhibitors and mutating of specific targeted sites needs to be further explored through in- vivo and in vitro models that can predict the regulation mechanism, resulting in a promising agent in cancer biology. The gene discussed is CHD4; the disease is cancer.